AgIS Capital is pleased to offer our first Annual State of the Harvest Report, which provides an overview of selected commodity markets. In this issue, we discuss the market for almonds, walnuts, and pistachios and analyze the factors impacting the performance of these farmland assets. We also highlight how diabetic drugs like Ozempic, Wegovy, and Mounjaro, all glucagon-like peptide-1 receptor agonists (GLP-1), could potentially impact consumer demand for healthy foods like walnuts, pistachios, and almonds. Finally, we discuss our near and longer-term outlook for the nut sector.